Your browser is no longer supported. Please, upgrade your browser.
PFE Pfizer Inc. daily Stock Chart
PFE [NYSE]
Pfizer Inc.
IndexDJIA S&P500 P/E23.68 EPS (ttm)1.81 Insider Own0.10% Shs Outstand5.64B Perf Week-0.37%
Market Cap240.95B Forward P/E13.96 EPS next Y3.06 Insider Trans-13.58% Shs Float5.56B Perf Month3.91%
Income10.67B PEG4.89 EPS next Q0.75 Inst Own74.90% Short Float1.20% Perf Quarter2.35%
Sales53.86B P/S4.47 EPS this Y-11.90% Inst Trans-2.17% Short Ratio2.93 Perf Half Y-3.17%
Book/sh10.43 P/B4.10 EPS next Y5.29% ROA7.10% Target Price45.00 Perf Year18.06%
Cash/sh2.06 P/C20.74 EPS next 5Y4.85% ROE17.40% 52W Range35.73 - 46.47 Perf YTD-2.04%
Dividend1.44 P/FCF44.34 EPS past 5Y1.00% ROI10.20% 52W High-7.98% Beta0.64
Dividend %3.37% Quick Ratio1.30 Sales past 5Y0.80% Gross Margin79.60% 52W Low19.68% ATR0.61
Employees92400 Current Ratio1.50 Sales Q/Q1.60% Oper. Margin23.30% RSI (14)59.14 Volatility1.50% 1.32%
OptionableYes Debt/Eq0.77 EPS Q/Q14.90% Profit Margin21.30% Rel Volume0.54 Prev Close42.50
ShortableYes LT Debt/Eq0.61 EarningsApr 30 BMO Payout69.60% Avg Volume22.67M Price42.76
Recom2.50 SMA201.47% SMA503.07% SMA2000.43% Volume12,261,810 Change0.61%
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jan-23-19Downgrade UBS Buy → Neutral
Dec-11-18Downgrade JP Morgan Overweight → Neutral
Nov-01-18Downgrade BMO Capital Markets Outperform → Market Perform
Jun-08-18Initiated Cantor Fitzgerald Overweight $45
Apr-05-18Downgrade Barclays Overweight → Equal Weight $41 → $38
Jan-29-18Reiterated SunTrust Hold $33 → $40
Sep-20-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-20-17Downgrade Credit Suisse Outperform → Neutral
May-16-17Downgrade Citigroup Neutral → Sell
Dec-02-16Initiated Guggenheim Neutral
Nov-02-16Downgrade Argus Buy → Hold
Oct-13-16Downgrade Jefferies Buy → Hold
Jun-20-16Reiterated Jefferies Buy $42 → $40
May-12-16Initiated Berenberg Hold $38
May-04-16Reiterated UBS Buy $36 → $38
Apr-18-16Resumed Goldman Neutral $35
Jun-14-19 10:07AM  Merck Plans Its First Investor Day in 5 Years. Heres What to Watch. Barrons.com
09:12AM  Dow 30 Stock Roundup: United Technologies-Raytheon Merger, Merck's Tilos Buyout Zacks
08:34AM  Amgen/Allergan Get FDA Nod for Herceptin Biosimilar Kanjinti Zacks
Jun-13-19 01:43PM  J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB -- Moody's assigns definitive ratings to six CMBS classes of J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB Moody's
08:24AM  Pfizer's (PFE) Xeljanz Effective As Monotherapy in RA Study Zacks
Jun-12-19 06:38PM  Galapagos Ends Enrollment in Osteoarthritis Study Before Time Zacks
06:21PM  Novartis Reports Data on Cosentyx for Psoriatic Arthritis Zacks
05:45PM  Pfizer (PFE) Gains As Market Dips: What You Should Know Zacks
10:36AM  Top Ranked Income Stocks to Buy for June 12th Zacks
08:33AM  Merck's Keytruda Wins FDA Nod for First-Line Head/Neck Cancer Zacks
08:28AM  Boost Your Portfolio's Health With These 3 Big Drug Stocks Zacks
08:00AM  Pfizer Announces Results from XELJANZ® XR (tofacitinib) ORAL Shift Study, The First Phase 3b/4 Study to Evaluate Methotrexate Withdrawal with a JAK Inhibitor Business Wire
Jun-10-19 01:35PM  INMB: TNF- Inhibition Associated with Decreased Risk of Developing Alzheimers Disease Zacks Small Cap Research
10:59AM  9 Hot Stocks to Buy Now InvestorPlace
09:39AM  TherapeuticsMD Enters Agreement to Market Drugs Outside US Zacks
07:23AM  Jim Cramer Weighs In On Tesla, PayPal And More Benzinga
Jun-07-19 10:50PM  PFIZER INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Pfizer Inc. - PFE PR Newswire
07:45AM  Why I'm Sticking With My 3 Worst-Performing Stocks of 2019 So Far Motley Fool
04:01AM  Germany's Stada buys six of GSK's consumer brands, eyes further deals Reuters
Jun-06-19 05:45PM  Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know Zacks
09:22AM  Lilly's Emgality Gets FDA Approval for Cluster Headache Zacks
09:18AM  Zacks Market Edge Highlights: Pfizer, Vanguard S&P 500 ETF, Global X Social Media ETF, Kraneshares China Internet ETF and Microsoft Zacks
08:50AM  3 Big Stock Charts for Thursday: Pfizer, Walmart and FleetCor Technologies InvestorPlace
Jun-05-19 01:30PM  Jeff Settleman, Ph.D., Joins Pfizer to Lead Oncology Research & Development Business Wire
12:21PM  How Merck reached new ground in the fight against cancer Yahoo Finance Video
11:44AM  Blueprint Medicines to File NDA for Avapritinib With FDA Zacks
11:05AM  Top Tips for Long-Term Stock Investors Zacks
10:46AM  Pfizer Stock Is The Biggest Pharma But Should You Buy It? Investor's Business Daily
09:51AM  The Zacks Analyst Blog Highlights: Pfizer, Coca-Cola, VMware, NIKE and AIG Zacks
09:05AM  Pfizer to Launch Several Drugs Despite Generic Headwinds Zacks
08:15AM  10 Jaw-Dropping Numbers About Cancer Drug Development -- and What They Mean for Investors Motley Fool
Jun-04-19 01:57PM  Top Research Reports for Pfizer, Coca-Cola & VMware Zacks
06:00AM  Ultimate Stock-Pickers' Top 10 Buys and Sells Morningstar
Jun-03-19 04:05PM  6 High-Yield Stocks GuruFocus.com
10:26AM  Blueprint Medicines' NDA for Avapritinib on Track for GIST Zacks
09:39AM  Merck's Keytruda Improves 5-Year Survival in Lung Cancer Zacks
08:05AM  Matinas BioPharma to Present at the 9th Annual LD Micro Invitational GlobeNewswire
Jun-01-19 09:53AM  Were Hedge Funds Right About Souring On Pfizer Inc. (PFE)? Insider Monkey
07:30AM  Novartis hopes Kisqali data will help narrow gap to blockbuster rival Reuters
May-31-19 08:29AM  Drug and Healthcare Stocks to Keep Your Portfolio Healthy InvestorPlace
06:32AM  Dow 30 Stock Roundup: BA's Dreamliner Order, MSFT LinkedIn's Drawbridge Buyout Plan Zacks
May-30-19 03:26PM  Pfizer opens $236M facility as region makes gains in biotech industry American City Business Journals
01:30PM  Should We Worry About Pfizer Inc.'s (NYSE:PFE) P/E Ratio? Simply Wall St.
12:59PM  Only five Dow stocks have gained in May as trade war drags on CNBC
09:31AM  Pfizer (PFE) Up 2.3% Since Last Earnings Report: Can It Continue? Zacks
May-29-19 09:03PM  Pfizer focuses on regional China after price cuts hit sales Financial Times
07:55PM  J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB -- Moody's assigns a provisional rating to One CMBS class of J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB Moody's
04:24PM  5 Pharmaceutical Stocks With Big Moats and Bridges Kiplinger
03:29PM  Merck (MRK) Up This Year So Far: Will the Momentum Continue? Zacks
10:31AM  Lilly In-Licenses Private Biotech's Non-Opoid Pain Candidate Zacks
09:52AM  Pro-choice groups lost in Alabama despite outspending the pro-life side by 100-to-1 MarketWatch
May-28-19 05:35PM  A hemophilia patient hero at zero, BioMarin to seek FDA OK for gene therapy. But will the effect last? American City Business Journals
03:56PM  J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB -- Moody's assigns provisional ratings to six CMBS classes of J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB Moody's
03:36PM  This Just In: Goldman Sachs Picks 4 Big Pharma Stocks to Buy Motley Fool
02:39PM  4 Drug and Health Stocks Pushing Higher InvestorPlace
11:48AM  Conatus Down More Than 60% in the Past 90 Days: Here's Why Zacks
11:30AM  British Columbia to be first Canadian province to switch patients to biosimilars Reuters
08:46AM  The Zacks Analyst Blog Highlights: Guardant, Illumina, Exact Sciences and Pfizer Zacks
08:32AM  Here are the biggest analyst calls of the day: Beyond Meat, Apple, Southwest, Pfizer, Roku & more CNBC
May-27-19 10:05AM  Dow on Longest Losing Streak in 8 Yrs: 5 Stocks Still Up in ETF Zacks
09:22AM  Pfizer's (PFE) Epilepsy Drug Lyrica Fails in Phase III Study Zacks
01:24AM  3 Peninsula biotech IPOs show off diversity of targets, seek to raise more than $400 million American City Business Journals
May-24-19 10:50PM  PFIZER INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Pfizer Inc. - PFE Business Wire
04:20PM  Pfizer's Lyrica doesn't meet endpoint in epilepsy study MarketWatch
04:00PM  Pfizer Announces Top-Line Results from Phase 3 Trial of LYRICA® (pregabalin) in Primary Generalized Tonic-Clonic Seizures Business Wire
01:15PM  Barrow, Hanley, Mewhinney & Strauss Trims Multiple Positions in 1st Quarter GuruFocus.com
09:25AM  3 Stocks to Win Big in the Fight Against Cancer Zacks
May-23-19 02:25PM  Greenwich Capital Commercial Funding Corp., 2005-GG3 -- Moody's affirms two and downgrades one class of GCCFC 2005-GG3 Moody's
02:12PM  Next level of support for Pioneer? Pfizer or J&J? The viewers #AskHalftime CNBC Videos
10:03AM  Alphabet to Aid Pharma Giants Enhance Clinical Trial Process Zacks
09:08AM  Lilly (LLY) Launches Half-Priced Version of Humalog Insulin Zacks
09:01AM  Stocks To Buy: Is It Time To Buy Or Sell These Large-Cap Stocks? Investor's Business Daily
May-21-19 05:36PM  Ocular's Glaucoma Drug Study Fails to Meet Primary Endpoint Zacks
09:00AM  Better Buy: AbbVie vs. Pfizer Motley Fool
08:46AM  Merck's Keytruda Fails in Late-Stage Breast Cancer Study Zacks
May-20-19 02:44PM  Primary Drivers of the Chinese Economy Investopedia
12:04PM  Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock InvestorPlace
May-19-19 09:00AM  Better Buy: Eli Lilly vs. Pfizer Motley Fool
May-18-19 06:30AM  Where Will Pfizer Be in 5 Years? Motley Fool
May-17-19 08:35AM  Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs Zacks
08:24AM  Dow 30 Stock Roundup: Walmart, Cisco Earnings Impress Zacks
May-16-19 09:40AM  Pfizer Gains After Being Named 'Top Pick' by Credit Suisse TheStreet.com
08:20AM  Pfizer's Eczema Candidate Meets All Goals in Phase III Study Zacks
08:08AM  Here are the biggest analyst calls of the day: Macy's, Pfizer, Owens Corning & more CNBC
08:06AM  Stocks making the biggest moves premarket: Walmart, Pfizer, PG&E, Sony, Tesla & more CNBC
08:00AM  Generic Drugs Are Stabilizing Can They Survive An Antitrust Scandal? Investor's Business Daily
May-15-19 05:01PM  Pfizer Oncology to Showcase New Data from Innovative Science That Address Patient Needs at ASCO 2019 Annual Meeting Business Wire
04:38PM  This Dow Jones Pharma Giant Is Now A 'Top Pick' Here's Why Investor's Business Daily
11:47AM  Teva Hits Fibonacci Support on Concerns Over Lawsuit Investopedia
09:27AM  Pfizer's Bavencio+Inlyta Combo Gets FDA Nod for Kidney Cancer Zacks
09:24AM  The Zacks Analyst Blog Highlights: Teva, Mylan, Novartis and Pfizer Zacks
07:50AM  The Daily Biotech Pulse: FDA Greenlights Pfizer-Merck KGAa's Kidney Cancer Combo Treatment, Adcom Disappointment For Daiichi Benzinga
07:46AM  AbbVie Settles Humira Litigation With Boehringer Ingelheim Zacks
07:12AM  Pfizer's atopic dermatitis treatment meets goals in late-stage study Reuters
07:00AM  Matinas BioPharma Announces a Research Collaboration with ViiV Healthcare to Evaluate Formulation of Antiviral Drug Candidates GlobeNewswire
06:55AM  Pfizer's dermatitis treatment meets main goals of late-stage study Reuters
06:45AM  Pfizer Announces Positive Top-Line Results from Phase 3 Study of Investigational Oral JAK1 Candidate, Abrocitinib (PF-04965842), in Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis Business Wire
May-14-19 08:25PM  FDA Approves BAVENCIO® (avelumab) plus Axitinib Combination for Patients with Advanced Renal Cell Carcinoma PR Newswire
07:44PM  FDA Approves BAVENCIO® (avelumab) Plus INLYTA® (axitinib) Combination for Patients with Advanced Renal Cell Carcinoma PR Newswire
09:18AM  Generic Drugmakers Face Antitrust Suit Alleging Price Fixing Zacks
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides consumer healthcare products that comprise over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names. Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Oncolytics Biotech Inc.; licensing agreement with BionTech AG; strategic alliance with Verily Life Sciences LLC; and collaboration agreements with Merck & Co., Inc. and Eli Lilly & Company, as well as with Merck KGaA and Nektar Therapeutics to develop a therapy for treating pancreatic cancer. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PFIZER INC10% OwnerMay 13Buy17.0050,000850,0003,249,973May 14 07:34 AM
MACKENZIE ALEXANDER RExecutive Vice PresidentApr 01Sale42.8315,000642,503110,094Apr 02 03:05 PM
JOHNSON RADY AExecutive Vice PresidentMar 15Sale41.138,700357,83159,797Mar 18 06:37 PM
READ IAN CExecutive ChairmanMar 04Sale43.2950,7882,198,4741,639,280Mar 06 04:03 PM
READ IAN CExecutive ChairmanMar 04Sale43.17530,07822,882,7021,109,202Mar 06 04:03 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale43.268,725377,444172,094Mar 06 03:29 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale43.1463,9982,760,698108,096Mar 06 03:29 PM
ROGERS DAWNExecutive Vice PresidentMar 04Sale42.9815,002644,79814,920Mar 05 04:55 PM
Dolsten MikaelPresident R&DMar 04Sale43.5249,0822,136,293289,126Mar 05 04:54 PM
Dolsten MikaelPresident R&DMar 01Option Exercise31.34106,1913,328,057438,679Mar 05 04:54 PM
Dolsten MikaelPresident R&DMar 01Sale43.56100,4714,376,852338,208Mar 05 04:54 PM
ROGERS DAWNExecutive Vice PresidentFeb 27Option Exercise32.2319,297621,94245,049Mar 01 07:47 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise32.2385,7632,764,141228,743Mar 01 07:47 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise32.23154,3744,975,474441,923Mar 01 07:47 PM
GOETTLER MICHAELGroup PresidentFeb 27Option Exercise32.2330,017967,44848,652Mar 01 07:37 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise32.2311,792380,05623,635Mar 01 07:37 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise32.2330,017967,44881,341Mar 01 07:37 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise32.2364,3222,073,098123,145Mar 01 07:37 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 27Option Exercise32.2381,4752,625,939416,278Mar 01 07:37 PM
BOURLA ALBERTChief Executive OfficerFeb 27Option Exercise32.2364,3222,073,098331,982Mar 01 07:29 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 27Option Exercise32.2325,729829,246121,743Mar 01 07:29 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise32.23182,2475,873,821588,177Mar 01 07:29 PM
YOUNG JOHN DGroup PresidentFeb 23Option Exercise21.0343,724919,516312,403Feb 26 07:45 PM
JOHNSON RADY AExecutive Vice PresidentFeb 23Option Exercise21.0318,004378,62461,182Feb 26 07:45 PM
BOURLA ALBERTChief Executive OfficerFeb 23Option Exercise21.0336,008757,248191,438Feb 26 07:45 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 23Option Exercise21.0387,4491,839,052388,024Feb 26 07:45 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 23Option Exercise21.03185,1853,894,441522,576Feb 26 07:45 PM
SUSMAN SALLYExecutive Vice PresidentFeb 23Option Exercise21.0397,7372,055,409205,833Feb 26 07:46 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 23Option Exercise21.0343,724919,51683,781Feb 26 07:45 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 23Option Exercise21.0341,615875,163144,164Feb 26 07:10 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 23Option Exercise21.0330,864649,070115,139Feb 26 07:10 PM
ROGERS DAWNExecutive Vice PresidentFeb 23Option Exercise21.0319,290405,66937,638Feb 26 07:10 PM
GOETTLER MICHAELGroup PresidentFeb 23Option Exercise21.0319,290405,66931,507Feb 26 07:11 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 01Sale42.755,000213,75040,057Feb 01 07:21 PM
Dolsten MikaelPresident R&DJan 31Option Exercise29.78125,9683,751,425362,051Feb 01 07:28 PM
LANKLER DOUGLAS MExecutive Vice PresidentJan 30Sale41.1938,8001,598,07145,057Feb 01 07:21 PM
READ IAN CChairman & CEONov 02Option Exercise26.641,100,20129,312,5881,760,958Nov 06 03:46 PM
PFIZER INC10% OwnerOct 15Buy18.0055,5561,000,00822,032,040Oct 17 05:17 PM
Dolsten MikaelPresident R&DSep 13Option Exercise24.56181,7124,462,167234,299Sep 17 04:08 PM
OLSON LAURIE JExecutive Vice PresidentAug 13Sale41.0010,214418,77472,672Aug 14 05:04 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentAug 03Sale39.5125,6421,013,171102,412Aug 06 03:19 PM
GOETTLER MICHAELGroup PresidentAug 01Sale39.7019,198762,11611,924Aug 03 03:38 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerAug 01Sale40.1626,8141,076,93383,846Aug 03 03:36 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentAug 01Sale40.0420,942838,5724,643Aug 03 03:35 PM
DAMELIO FRANK AExecutive Vice PresidentAug 01Sale40.00150,4846,019,360337,391Aug 03 03:33 PM
SUSMAN SALLYExecutive Vice PresidentJul 20Sale37.2240,3811,502,925115,096Jul 24 01:09 PM
READ IAN CChairman & CEOJul 16Sale37.36486,75318,186,315659,440Jul 17 04:59 PM